Progressive increase in activation delay during premature stimulation is related to ventricular fibrillation in Brugada syndrome.

Brugada syndrome activation delay electrophysiologic study premature stimulation ventricular fibrillation

Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
07 2021
Historique:
revised: 01 04 2021
received: 16 01 2021
accepted: 14 04 2021
pubmed: 1 5 2021
medline: 11 8 2021
entrez: 30 4 2021
Statut: ppublish

Résumé

The local conduction delay has been deemed to play an important role in the perpetuation of ventricular fibrillation (VF) in Brugada syndrome (BrS). We evaluated the relationship between the activation delay during programmed stimulation and cardiac events in BrS patients. This study included 47 consecutive BrS patients who underwent an electrophysiological study and received implantable cardiac defibrillator therapy. We divided the patients into two groups based on whether they had developed VF (11 patients) or not (36 patients) during the follow-up period of 89 ± 53 months. The activation delay was assessed using the interval between the stimulus and the QRS onset during programmed stimulation. The mean increase in delay (MID) was used to characterize the conduction curves. The MID at the right ventricular outflow tract (RVOT) was significantly greater in patients with VF (4.5 ± 1.2 ms) than in those without VF (2.2 ± 0.9 ms) (p < .001). A receiver operating characteristics curve analysis indicated that the optimal cut-off point for discriminating VF occurrence was 3.3 with 88.9% sensitivity and 91.3% specificity. Furthermore, patients with an MID at the RVOT ≥ 3.3 ms showed significantly higher rates of VF recurrence than those with an MID at the RVOT < 3.3 ms (p < .001). The clinical characteristics, including the signal-averaged electrocardiogram measurement and VF inducibility were similar between the two groups. A prolonged MID at the RVOT was associated with VF and maybe an additional electrophysiological risk factor for VF in BrS patients.

Identifiants

pubmed: 33928698
doi: 10.1111/jce.15065
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1939-1946

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Brugada P , Brugada J . Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992;20:1391-1396.
Antzelevitch C , Yan GX , Ackerman MJ , et al. J-wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge. Heart Rhythm. 2016;13:e295-e324.
Wilde AA , Postema PG , Di Diego JM , et al. The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization. J Mol Cell Cardiol. 2010;49:543-553.
Yan GX , Antzelevitch C . Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation. 1999;100:1660-1666.
Nagase S , Kusano KF , Morita H , et al. Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome: using the epicardial lead. J Am Coll Cardiol. 2002;39:1992-1995.
Smits JP , Eckardt L , Probst V , et al. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol. 2002;40:350-356.
Kanda M , Shimizu W , Matsuo K , et al. Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome. J Am Coll Cardiol. 2002;39:1799-1805.
Ikeda T , Sakurada H , Sakabe K , et al. Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification. J Am Coll Cardiol. 2001;37:1628-1634.
Ciconte G , Santinelli V , Vicedomini G , et al. Non-invasive assessment of the arrhythmogenic substrate in Brugada syndrome using signal-averaged electrocardiogram: clinical implications from a prospective clinical trial. Europace. 2019;21:1900-1910.
Aiba T , Shimizu W , Hidaka I , et al. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study. J Am Coll Cardiol. 2006;47:2074-2085.
Furushima H , Chinushi M , Iijima K , Izumi D , Hosaka Y , Aizawa Y . Significance of early onset and progressive increase of activation delay during premature stimulation in Brugada syndrome. Circ J. 2009;73:1408-1415.
Priori SG , Blomström-Lundqvist C , Mazzanti A , et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36:2793-2867.
Hanley JA , McNeil BJ . The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
Bass BG . Restitution of the action potential in cat papillary muscle. Am J Physiol. 1975;228:1717-1724.
Chinushi M , Restivo M , Caref EB , El-Sherif N . Electrophysiological basis of arrhythmogenicity of QT/T alternans in the long-QT syndrome: tridimensional analysis of the kinetics of cardiac repolarization. Circ Res. 1998;83:614-628.
Izumi D , Chinushi M , Iijima K , et al. Effects of bepridil versus E-4031 on transmural ventricular repolarization and inducibility of ventricular tachyarrhythmias in the dog. Pacing Clin Electrophysiol. 2010;33:950-959.
Gaeta SA , Christini DJ . Non-linear dynamics of cardiac alternans: subcellular to tissue-level mechanisms of arrhythmia. Front Physiol. 2012;3:157.
Karma A . Electrical alternans and spiral wave breakup in cardiac tissue. Chaos (Woodbury, NY). 1994;4:461-472.
Qu Z , Weiss JN , Garfinkel A . Cardiac electrical restitution properties and stability of reentrant spiral waves: a simulation study. Am J Physiol. 1999;276:H269-H283.
Koller ML , Maier SK , Gelzer AR , Bauer WR , Meesmann M , Gilmour RF Jr. Altered dynamics of action potential restitution and alternans in humans with structural heart disease. Circulation. 2005;112:1542-1548.
Ashino S , Watanabe I , Kofune M , et al. Abnormal action potential duration restitution property in the right ventricular outflow tract in Brugada syndrome. Cir J. 2010;74:664-670.
Franz MR . The electrical restitution curve revisited: steep or flat slope-which is better? J Cardiovasc Electrophysiol. 2003;14:S140-S147.
Weiss JN , Karma A , Shiferaw Y , Chen PS , Garfinkel A , Qu Z . From pulsus to pulseless: the saga of cardiac alternans. Circ Res. 2006;98:1244-1253.
Mironov S , Jalife J , Tolkacheva EG . Role of conduction velocity restitution and short-term memory in the development of action potential duration alternans in isolated rabbit hearts. Circulation. 2008;118:17-25.
Bourgeois EB , Reeves HD , Walcott GP , Rogers JM . Panoramic optical mapping shows wavebreak at a consistent anatomical site at the onset of ventricular fibrillation. Cardiovasc Res. 2012;93:272-279.
Weiss JN , Chen PS , Qu Z , Karagueuzian HS , Garfinkel A . Ventricular fibrillation: how do we stop the waves from breaking? Circ Res. 2000;87:1103-1107.
Zheng Y , Wei D , Zhu X , Chen W , Fukuda K , Shimokawa H . Ventricular fibrillation mechanisms and cardiac restitutions: an investigation by simulation study on whole-heart model. Comput Biol Med. 2015;63:261-268.
Nademanee K , Veerakul G , Chandanamattha P , et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation. 2011;123:1270-1279.
Pieroni M , Notarstefano P , Oliva A , et al. Electroanatomic and pathologic right ventricular outflow tract abnormalities in patients with Brugada syndrome. J Am Coll Cardiol. 2018;72:2747-2757.
Nademanee K , Raju H , de Noronha SV , et al. Fibrosis, connexin-43, and conduction abnormalities in the Brugada syndrome. J Am Coll Cardiol. 2015;66:1976-1986.
Coronel R , Casini S , Koopmann TT , et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation. 2005;112:2769-2777.
Ajiro Y , Hagiwara N , Kasanuki H . Assessment of markers for identifying patients at risk for life-threatening arrhythmic events in Brugada syndrome. J Cardiovasc Electrophysiol. 2005;16:45-51.
Huang Z , Patel C , Li W , et al. Role of signal-averaged electrocardiograms in arrhythmic risk stratification of patients with Brugada syndrome: a prospective study. Heart Rhythm. 2009;6:1156-1162.

Auteurs

Yuki Hasegawa (Y)

Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Daisuke Izumi (D)

Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Yasuhiro Ikami (Y)

Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Sou Otsuki (S)

Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Nobue Yagihara (N)

Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Kenichi Iijima (K)

Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Masaomi Chinushi (M)

Cardiovascular Research of Graduate School of Health Sciences, Niigata, Japan.

Tohru Minamino (T)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH